V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003868 | 280002848 | null | null | Curative (C) | 2014-05-30 | 2014-06-07 | CISPLATIN + FLUOROURACIL | N | null | 280026306 | CISPLATIN + FLUOROURACIL |
| 280003869 | 280002849 | 1.85 | 70.2 | null | null | 2014-10-15 | Cisplatin +Fluorouracil (3 wk) | N | N | 280026309 | CISPLATIN + FLUOROURACIL |
| 280003870 | 280002850 | 1.74 | 96 | Curative (C) | 2016-07-02 | 2016-07-02 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280026311 | CISPLATIN + FLUOROURACIL |
| 280003871 | 280007397 | 1.55 | 89.9 | Curative (C) | 2015-08-26 | 2015-09-08 | Cetuximab + Radiotherapy Load | 2 | Y | 280026313 | CETUXIMAB + RT |
| 280003872 | 280007397 | 1.81 | 63 | Curative (C) | 2017-05-09 | 2017-05-10 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280026313 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003873 | 280002851 | 1.61 | 70 | Curative (C) | null | 2017-06-02 | Cetuximab + Radiotherapy Load | N | Y | 280026318 | CETUXIMAB + RT |
| 280003874 | 280002851 | 1.69 | 107.35 | null | 2016-02-01 | 2016-02-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280026318 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003875 | 280009771 | 1.69 | 86 | Curative (C) | 2017-11-27 | 2017-11-27 | Cetuximab + Radiotherapy Load | 2 | N | 280026321 | CETUXIMAB + RT |
| 280003876 | 280002852 | 1.58 | 81 | Neo-adjuvant (N) | 2014-08-04 | 2014-08-10 | DOXORUBICIN + IFOSFAMIDE | N | N | 280026322 | DOXORUBICIN + IFOSFAMIDE |
| 280003877 | 280007399 | null | null | Curative (C) | 2013-06-21 | 2013-06-26 | CISPLATIN + FLUOROURACIL | N | N | 280026325 | CISPLATIN + FLUOROURACIL |
| 280003878 | 280002853 | 1.72 | 69 | Curative (C) | 2017-09-03 | 2017-09-21 | Cetuximab + Radiotherapy Load | 2 | N | 280026326 | CETUXIMAB + RT |
| 280003879 | 280007400 | 1.69 | 75.1 | null | 2016-02-11 | 2016-05-02 | Cetuximab + Radiotherapy Load | 02 | N | 280026327 | CETUXIMAB + RT |
| 280003880 | 280002854 | 1.68 | 69 | Curative (C) | 2015-05-29 | 2015-05-29 | Cetuximab + Radiotherapy Load | 2 | Y | 280026329 | CETUXIMAB + RT |
| 280003881 | 280007401 | 1.65 | 96.8 | Curative (C) | 2015-03-04 | 2015-03-14 | Cetuximab + Radiotherapy Load | 02 | null | 280026331 | CETUXIMAB + RT |
| 280003882 | 280002855 | 1.85 | 79.4 | Neo-adjuvant (N) | 2014-10-12 | 2014-10-16 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280026333 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003883 | 280002856 | null | null | Curative (C) | 2015-06-16 | 2015-06-30 | CETUXIMAB + RT | 02 | Y | 280026334 | CETUXIMAB + RT |
| 280003884 | 280002856 | 1.5 | 148 | Curative (C) | 2014-01-23 | 2014-02-07 | Cetuximab + Radiotherapy Load | 02 | null | 280026334 | CETUXIMAB + RT |
| 280003885 | 280002856 | 1.5 | 76 | Curative (C) | 2017-10-28 | 2017-11-05 | Cetuximab + Radiotherapy Maint | N | Y | 280026334 | CETUXIMAB + RT |
| 280003886 | 280002857 | 1.58 | 90.4 | null | 2016-12-20 | 2017-01-25 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 280026342 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003887 | 280002857 | 1.66 | 68.7 | Palliative (P) | 2017-08-04 | 2017-08-11 | CETUXIMAB | 01 | N | 280026342 | CETUXIMAB |
| 280003888 | 280002857 | 1.7 | 74.7 | Palliative (P) | 2017-11-30 | 2017-12-21 | Carboplatin + Etoposide IV 3 day | 2 | N | 280026342 | CARBOPLATIN + ETOPOSIDE |
| 280003889 | 280002857 | 1.7 | null | Palliative (P) | 2016-10-28 | 2016-10-28 | Carboplatin + Paclitaxel (weekly) | null | null | 280026342 | CARBOPLATIN + PACLITAXEL |
| 280003890 | 280002858 | 1.5 | 60.4 | Palliative (P) | 2013-12-17 | 2013-12-31 | Cisplatin+Gemcitabine (gallbladder) | 01 | N | 280026349 | CISPLATIN + GEMCITABINE |
| 280003891 | 280002859 | 1.74 | 45 | Curative (C) | 2016-11-04 | 2016-11-04 | Trial Unspecified | N | N | 280026350 | TRIAL |
| 280003892 | 280007404 | 0 | 98 | Palliative (P) | 2017-12-18 | 2017-12-18 | STS Non-Rhabdo EpSSG 2005 Ifos Dox | N | N | 280026352 | NOT MATCHED |
| 280003893 | 280009774 | 1.53 | 72.7 | Palliative (P) | 2017-05-31 | 2017-06-11 | Carboplatin AUC 6 - 10 | N | N | 280026353 | CARBOPLATIN |
| 280003894 | 280009774 | 1.61 | 1.8 | Palliative (P) | 2017-06-24 | 2017-07-07 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 280026353 | CISPLATIN + GEMCITABINE |
| 280003895 | 280002860 | null | 55.9 | Palliative (P) | 2015-04-07 | 2015-04-21 | Carboplatin AUC 6 - 10 | N | N | 280026355 | CARBOPLATIN |
| 280003896 | 280002860 | 1.78 | 96 | Palliative (P) | 2019-02-28 | 2019-03-06 | Trial Unspecified | Y | N | 280026355 | TRIAL |
| 280003897 | 280002860 | 1.73 | 70.7 | Palliative (P) | 2014-04-23 | 2014-05-01 | CETUXIMAB | 2 | N | 280026355 | CETUXIMAB |
| 280003898 | 280010942 | 1.79 | 78 | Palliative (P) | 2017-12-24 | 2017-12-24 | CARBOPLATIN + RT | 02 | null | 280026360 | CARBOPLATIN + RT |
| 280003899 | 280010942 | 1.8 | null | Palliative (P) | 2014-10-21 | 2014-10-21 | EOX | N | N | 280026360 | EOX |
| 280003900 | 280002861 | 1.75 | 65 | Palliative (P) | 2015-08-22 | 2015-08-22 | CARBOPLATIN | N | N | 280026363 | CARBOPLATIN |
| 280003901 | 280002861 | 1.72 | null | Palliative (P) | null | 2014-10-13 | CARBOPLATIN + RT | null | null | 280026363 | CARBOPLATIN + RT |
| 280003902 | 280002862 | 0 | 55.6 | null | 2012-07-07 | 2013-07-18 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | 280026365 | NOT MATCHED |
| 280003903 | 280007407 | 1.85 | 83.6 | Palliative (P) | 2012-07-10 | 2012-07-18 | CETUXIMAB | N | N | 280026367 | CETUXIMAB |
| 280003904 | 280002863 | 1.78 | null | Palliative (P) | 2015-01-26 | 2015-01-26 | Trial Unspecified | N | N | 280026372 | TRIAL |
| 280003905 | 280002863 | 1.74 | 97.9 | Palliative (P) | 2014-01-15 | 2014-01-21 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 280026372 | CARBOPLATIN + PACLITAXEL |
| 280003906 | 280002864 | 1.68 | null | Palliative (P) | null | 2013-08-23 | Cetuximab 7 day (Cycle 1) | N | N | 280026376 | CETUXIMAB |
| 280003907 | 280002865 | 1.73 | 68 | null | 2018-01-22 | 2018-01-22 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 280026381 | CARBOPLATIN + PACLITAXEL |
| 280003908 | 280007409 | 1.64 | null | Palliative (P) | 2015-07-04 | 2015-07-16 | EOX | N | N | 280026383 | EOX |
| 280003909 | 280009776 | null | null | null | 2014-02-19 | 2014-02-23 | EW EuroEwing 2012 Arm B VDC | 02 | N | 280026385 | TRIAL |
| 280003910 | 280009776 | 1.73 | 86.8 | Palliative (P) | 2014-01-03 | 2014-01-03 | Cetuximab 7 day (Cycle 1) | N | N | 280026385 | CETUXIMAB |
| 280003911 | 280011537 | 1.67 | null | Palliative (P) | 2016-08-27 | 2016-09-16 | Cetuximab 7 day (Cycle 1) | 02 | N | 280026389 | CETUXIMAB |
| 280003912 | 280011537 | 1.73 | null | null | 2015-09-03 | 2015-09-03 | CARBOPLATIN + RT | null | null | 280026389 | CARBOPLATIN + RT |
| 280003913 | 280011537 | 1.55 | 54.8 | Palliative (P) | 2015-12-30 | 2016-01-20 | CISPLATIN + GEMCITABINE | N | N | 280026389 | CISPLATIN + GEMCITABINE |
| 280003914 | 280002866 | null | null | Palliative (P) | 2013-04-06 | 2013-04-19 | CISPLATIN + GEMCITABINE | N | N | 280026394 | CISPLATIN + GEMCITABINE |
| 280003915 | 280002867 | 1.75 | 71.1 | null | 2017-12-04 | 2017-12-04 | Trial Unspecified | Y | N | 280026396 | TRIAL |
| 280003916 | 280002868 | 1.63 | 65.6 | Palliative (P) | 2016-09-04 | 2016-09-04 | CARBOPLATIN + RT | N | N | 280026397 | CARBOPLATIN + RT |
| 280003917 | 280002869 | 1.73 | null | Palliative (P) | 2018-03-28 | 2018-04-08 | Trial Unspecified | null | null | 280026398 | TRIAL |